365 related articles for article (PubMed ID: 33308936)
21. Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection.
Labò N; Ohnuki H; Tosato G
Cells; 2020 Jun; 9(7):. PubMed ID: 32629875
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
Maruhashi T; Higashi Y
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
Wahl A; Gralinski LE; Johnson CE; Yao W; Kovarova M; Dinnon KH; Liu H; Madden VJ; Krzystek HM; De C; White KK; Gully K; Schäfer A; Zaman T; Leist SR; Grant PO; Bluemling GR; Kolykhalov AA; Natchus MG; Askin FB; Painter G; Browne EP; Jones CD; Pickles RJ; Baric RS; Garcia JV
Nature; 2021 Mar; 591(7850):451-457. PubMed ID: 33561864
[TBL] [Abstract][Full Text] [Related]
24. Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19-related Acute Respiratory Distress Syndrome.
Gerard L; Lecocq M; Bouzin C; Hoton D; Schmit G; Pereira JP; Montiel V; Plante-Bordeneuve T; Laterre PF; Pilette C
Am J Respir Crit Care Med; 2021 Nov; 204(9):1024-1034. PubMed ID: 34449302
[No Abstract] [Full Text] [Related]
25. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
26. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.
Margaroli C; Benson P; Sharma NS; Madison MC; Robison SW; Arora N; Ton K; Liang Y; Zhang L; Patel RP; Gaggar A
Cell Rep Med; 2021 Apr; 2(4):100242. PubMed ID: 33778787
[TBL] [Abstract][Full Text] [Related]
27. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19.
Attiq A; Yao LJ; Afzal S; Khan MA
Int Immunopharmacol; 2021 Dec; 101(Pt B):108255. PubMed ID: 34688149
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
Datta PK; Liu F; Fischer T; Rappaport J; Qin X
Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
[TBL] [Abstract][Full Text] [Related]
29. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.
Abdelmoaty MM; Yeapuri P; Machhi J; Olson KE; Shahjin F; Kumar V; Zhou Y; Liang J; Pandey K; Acharya A; Byrareddy SN; Mosley RL; Gendelman HE
Front Immunol; 2021; 12():741502. PubMed ID: 34671355
[TBL] [Abstract][Full Text] [Related]
30. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells.
Lamers MM; van der Vaart J; Knoops K; Riesebosch S; Breugem TI; Mykytyn AZ; Beumer J; Schipper D; Bezstarosti K; Koopman CD; Groen N; Ravelli RBG; Duimel HQ; Demmers JAA; Verjans GMGM; Koopmans MPG; Muraro MJ; Peters PJ; Clevers H; Haagmans BL
EMBO J; 2021 Mar; 40(5):e105912. PubMed ID: 33283287
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
Harrell CR; Jovicic BP; Djonov V; Volarevic V
Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
Huang J; Hume AJ; Abo KM; Werder RB; Villacorta-Martin C; Alysandratos KD; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Olejnik J; Suder EL; Bullitt E; Hinds A; Sharma A; Bosmann M; Wang R; Hawkins F; Burks EJ; Saeed M; Wilson AA; Mühlberger E; Kotton DN
Cell Stem Cell; 2020 Dec; 27(6):962-973.e7. PubMed ID: 32979316
[TBL] [Abstract][Full Text] [Related]
33. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.
Grant RA; Morales-Nebreda L; Markov NS; Swaminathan S; Querrey M; Guzman ER; Abbott DA; Donnelly HK; Donayre A; Goldberg IA; Klug ZM; Borkowski N; Lu Z; Kihshen H; Politanska Y; Sichizya L; Kang M; Shilatifard A; Qi C; Lomasney JW; Argento AC; Kruser JM; Malsin ES; Pickens CO; Smith SB; Walter JM; Pawlowski AE; Schneider D; Nannapaneni P; Abdala-Valencia H; Bharat A; Gottardi CJ; Budinger GRS; Misharin AV; Singer BD; Wunderink RG;
Nature; 2021 Feb; 590(7847):635-641. PubMed ID: 33429418
[TBL] [Abstract][Full Text] [Related]
34. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
35. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
[TBL] [Abstract][Full Text] [Related]
36. Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies.
Puzyrenko A; Jacobs ER; Sun Y; Felix JC; Sheinin Y; Ge L; Lai S; Dai Q; Gantner BN; Nanchal R; North PE; Simpson PM; Rui H; Benjamin IJ
Cell Stress Chaperones; 2021 Sep; 26(5):859-868. PubMed ID: 34382151
[TBL] [Abstract][Full Text] [Related]
37. Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation.
Suess C; Hausmann R
Int J Legal Med; 2020 Jul; 134(4):1285-1290. PubMed ID: 32504146
[TBL] [Abstract][Full Text] [Related]
38. S100A8 may govern hyper-inflammation in severe COVID-19.
Deguchi A; Yamamoto T; Shibata N; Maru Y
FASEB J; 2021 Sep; 35(9):e21798. PubMed ID: 34339064
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.
Xia B; Shen X; He Y; Pan X; Liu FL; Wang Y; Yang F; Fang S; Wu Y; Duan Z; Zuo X; Xie Z; Jiang X; Xu L; Chi H; Li S; Meng Q; Zhou H; Zhou Y; Cheng X; Xin X; Jin L; Zhang HL; Yu DD; Li MH; Feng XL; Chen J; Jiang H; Xiao G; Zheng YT; Zhang LK; Shen J; Li J; Gao Z
Cell Res; 2021 Aug; 31(8):847-860. PubMed ID: 34112954
[TBL] [Abstract][Full Text] [Related]
40. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
